Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Craigbadon Nov 01, 2016 9:28pm
103 Views
Post# 25413445

RE:RE:Opinion on Cross Currency Swap

RE:RE:Opinion on Cross Currency SwapNo one knows the true impact of the UK bill that is likely to pass in the spring. After watching the parliamentary proceedings I can say that the company and its subsidiaries were named several times. I would find it shocking if any fund managers that could actually move the stock and actually hold it for any length of time would ever touch this now. The market is forward looking, with the overhang of this bill, the Cma investigation, insider selling and the class action lawsuit the stock will remain toxic for some time. This is just a battleground for long and short traders looking to scalp. I obviously have a short bias and I don't see any reason for this to change anytime soon.

cg16 wrote: Rye, I read a report from Scotia that came out yesterday and they reiterate $4.50 TP and sector perform. They said they expect $203m Rev ($58m from US), $115m adj ebitda, and $.91 adj EPS.. they did say that risk is on the downside.. they think the concensus is abit too high ($207m, $123m, $1.04). 
seems to me the share price this week is already saying that results aren't good.


<< Previous
Bullboard Posts
Next >>